Published in Exp Ther Med on June 14, 2016
Alzheimer's disease. N Engl J Med (2010) 13.13
Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov (2006) 11.77
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.67
Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N Engl J Med (1999) 3.21
Alcohol intake and risk of dementia. J Am Geriatr Soc (2004) 2.90
Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med (2012) 2.77
Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing (2008) 2.28
Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry (2009) 2.08
Prospective study of alcohol consumption and risk of dementia in older adults. JAMA (2003) 1.98
Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology (2002) 1.96
Intake of flavonoids and risk of dementia. Eur J Epidemiol (2000) 1.85
Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci (2002) 1.83
Ethanol and brain damage. Curr Opin Pharmacol (2005) 1.80
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) (1997) 1.77
Alcohol consumption impairs detection of performance errors in mediofrontal cortex. Science (2002) 1.66
Cognitive function after 11.5 years of alcohol use: relation to alcohol use. Am J Epidemiol (2002) 1.64
Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol (2012) 1.64
Cellular and molecular neuroscience of alcoholism. Physiol Rev (1997) 1.61
Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J (2006) 1.49
Acute alcohol effects on cognitive function in social drinkers: their relationship to drinking habits. Psychopharmacology (Berl) (2002) 1.48
Resveratrol--a boon for treating Alzheimer's disease? Brain Res Rev (2006) 1.40
Moderate alcohol consumption and cognitive risk. Neuropsychiatr Dis Treat (2011) 1.26
Brain shrinkage in alcoholics: a decade on and what have we learned? Prog Neurobiol (1999) 1.25
A review on Alzheimer's disease pathophysiology and its management: an update. Pharmacol Rep (2014) 1.23
Alcohol consumption and cognitive function in late life: a longitudinal community study. Neurology (2005) 1.20
Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project. J Neurol Neurosurg Psychiatry (2000) 1.19
FDG-PET findings in the Wernicke-Korsakoff syndrome. Cortex (2003) 1.15
Alcohol consumption and incidence of dementia in a community sample aged 75 years and older. J Clin Epidemiol (2002) 1.08
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Int J Geriatr Psychiatry (2012) 1.08
Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers. Protein Sci (2012) 1.05
Do alcoholics drink their neurons away? Lancet (1993) 1.02
Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration. J Alzheimers Dis (2009) 1.01
Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp Neurol (2012) 1.01
The neuropsychological profile of alcohol-related dementia suggests cortical and subcortical pathology. Dement Geriatr Cogn Disord (2005) 0.98
Relationship between ethanol-induced changes in brain regional metabolism and its motor, behavioural and cognitive effects. Alcohol Alcohol (2003) 0.98
Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. J Alzheimers Dis (2011) 0.97
Resveratrol and Alzheimer's disease: message in a bottle on red wine and cognition. Front Aging Neurosci (2014) 0.96
Alcohol use and the risk of developing Alzheimer's disease. Alcohol Res Health (2001) 0.95
Alcohol-related dementia: validation of diagnostic criteria. Am J Geriatr Psychiatry (2003) 0.94
Impairment in memory function and neurodegenerative changes in the cholinergic basal forebrain system induced by chronic intake of ethanol. J Neural Transm Suppl (1994) 0.94
Light to moderate alcohol consumption is associated with better cognitive function among older male veterans receiving primary care. J Geriatr Psychiatry Neurol (2006) 0.94
Dose-related impact of alcohol consumption on cognitive function in advanced age: results of a multicenter survey. Alcohol Clin Exp Res (2001) 0.91
Butanol extract of Ecklonia cava prevents production and aggregation of beta-amyloid, and reduces beta-amyloid mediated neuronal death. Food Chem Toxicol (2011) 0.88
Self-reported alcohol intake and cognition in aging twins. J Stud Alcohol (1995) 0.87
The chronic effects of alcohol on memory. A contrast between a unitary and dual system approach. Recent Dev Alcohol (1987) 0.85
Novel role of red wine-derived polyphenols in the prevention of Alzheimer's disease dementia and brain pathology: experimental approaches and clinical implications. Planta Med (2012) 0.84
Effect of genetic variation in LRRTM3 on risk of Alzheimer disease. Arch Neurol (2012) 0.82
Risk factors for cerebral degenerative changes and dementia. Eur Neurol (1998) 0.82
Alcoholism: protein expression profiles in a human hippocampal model. Expert Rev Proteomics (2008) 0.82
Are tobacco and alcohol use related to Alzheimer's disease? A critical assessment of the evidence and its implications. Addict Biol (1996) 0.81
The impact of alcohol on Alzheimer's disease: a systematic review. Aging Ment Health (2012) 0.81
Polymorphisms in the aldehyde dehydrogenase 2 and dopamine β hydroxylase genes are not associated with Alzheimer's disease. J Neural Transm (Vienna) (2013) 0.76
Changes in Mini-Mental State Examination score in Alzheimer's disease patients after stopping habitual drinking. Psychogeriatrics (2013) 0.76
Alzheimer's disease and alcoholism: possible interactions. Alcohol (1992) 0.76
Effect of alcohol on diethylnitrosamine-induced hepatic toxicity: Critical role of ROS, lipid accumulation, and mitochondrial dysfunction. Exp Toxicol Pathol (2015) 0.76
Mood Disorders Secondary to Drugs and Pharmacologic Agents. Semin Clin Neuropsychiatry (1997) 0.76
Role of oxidative stress in Alzheimer's disease. Biomed Rep (2016) 0.95
Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep (2016) 0.87
Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches. Oncol Lett (2016) 0.76
Pain control by melatonin: Physiological and pharmacological effects. Exp Ther Med (2016) 0.75
Chemotherapy-induced peripheral neuropathy. Biomed Rep (2017) 0.75
Microwaves and Alzheimer's disease. Exp Ther Med (2016) 0.75
Endocannabinoid system: Role in depression, reward and pain control (Review). Mol Med Rep (2016) 0.75
Huntington's disease: Molecular basis of pathology and status of current therapeutic approaches. Exp Ther Med (2016) 0.75
Role of physical exercise in Alzheimer's disease. Biomed Rep (2016) 0.75
Proteasome inhibitors in glioblastoma. Oncol Lett (2017) 0.75
Multiple sclerosis: Pathology, diagnosis and treatments. Exp Ther Med (2017) 0.75